Cargando…
Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
BACKGROUND: CpG islands (CGIs) are interspersed DNA sequences that have unusually high CpG ratios and GC contents. CGIs are typically located in the promoter of protein-coding genes. They normally lack DNA methylation but become hypermethylated and induce repression of associated genes in cancer. Ho...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989897/ https://www.ncbi.nlm.nih.gov/pubmed/27534853 http://dx.doi.org/10.1186/s12920-016-0198-1 |
_version_ | 1782448623957573632 |
---|---|
author | Bae, Min Gyun Kim, Jeong Yeon Choi, Jung Kyoon |
author_facet | Bae, Min Gyun Kim, Jeong Yeon Choi, Jung Kyoon |
author_sort | Bae, Min Gyun |
collection | PubMed |
description | BACKGROUND: CpG islands (CGIs) are interspersed DNA sequences that have unusually high CpG ratios and GC contents. CGIs are typically located in the promoter of protein-coding genes. They normally lack DNA methylation but become hypermethylated and induce repression of associated genes in cancer. However, the biological functions of non-promoter CGIs (orphan CGIs) largely remain unclear. RESULTS: Here, we identify orphan CGIs that do not map to the promoter of any protein-coding or non-coding transcripts but possess chromatin and transcriptional marks that reflect enhancer activity (termed eCGIs). They exhibit three-dimensional chromatin looping toward multiple target genes with high affinity. Intriguingly, transcription regulators were frequently associated with such CGI-containing enhancers. Remarkably, our analyses in cell lines and clinical tissues showed that eCGIs have more dynamic DNA methylation changes in cancer relative to promoter CGIs. The observed eCGI hypermethylation was accompanied by a loss of enhancer marks and transcriptional inactivation of the target genes. CONCLUSION: Our results suggest that eCGIs may constitute a distinct class of enhancers and perform a more instrumental role in tumorigenesis than typical CGIs in gene promoters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12920-016-0198-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4989897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49898972016-08-30 Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer Bae, Min Gyun Kim, Jeong Yeon Choi, Jung Kyoon BMC Med Genomics Research BACKGROUND: CpG islands (CGIs) are interspersed DNA sequences that have unusually high CpG ratios and GC contents. CGIs are typically located in the promoter of protein-coding genes. They normally lack DNA methylation but become hypermethylated and induce repression of associated genes in cancer. However, the biological functions of non-promoter CGIs (orphan CGIs) largely remain unclear. RESULTS: Here, we identify orphan CGIs that do not map to the promoter of any protein-coding or non-coding transcripts but possess chromatin and transcriptional marks that reflect enhancer activity (termed eCGIs). They exhibit three-dimensional chromatin looping toward multiple target genes with high affinity. Intriguingly, transcription regulators were frequently associated with such CGI-containing enhancers. Remarkably, our analyses in cell lines and clinical tissues showed that eCGIs have more dynamic DNA methylation changes in cancer relative to promoter CGIs. The observed eCGI hypermethylation was accompanied by a loss of enhancer marks and transcriptional inactivation of the target genes. CONCLUSION: Our results suggest that eCGIs may constitute a distinct class of enhancers and perform a more instrumental role in tumorigenesis than typical CGIs in gene promoters. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12920-016-0198-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-12 /pmc/articles/PMC4989897/ /pubmed/27534853 http://dx.doi.org/10.1186/s12920-016-0198-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Bae, Min Gyun Kim, Jeong Yeon Choi, Jung Kyoon Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer |
title | Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer |
title_full | Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer |
title_fullStr | Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer |
title_full_unstemmed | Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer |
title_short | Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer |
title_sort | frequent hypermethylation of orphan cpg islands with enhancer activity in cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989897/ https://www.ncbi.nlm.nih.gov/pubmed/27534853 http://dx.doi.org/10.1186/s12920-016-0198-1 |
work_keys_str_mv | AT baemingyun frequenthypermethylationoforphancpgislandswithenhanceractivityincancer AT kimjeongyeon frequenthypermethylationoforphancpgislandswithenhanceractivityincancer AT choijungkyoon frequenthypermethylationoforphancpgislandswithenhanceractivityincancer |